Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 4:57 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC. ALPN | GREAT POINT PARTNERS LLC | 3,637,718 7.92% | 189,197 (+5.49%) | View |
2023-02-13 4:10 pm Purchase | 13G | AVALO THERAPEUTICS INC PAR AVTX | GREAT POINT PARTNERS LLC | 974,639 7.12% | 974,639 (New Position) | View |
2022-12-01 4:03 pm Purchase | 13G | OPTINOSE INC OPTN | GREAT POINT PARTNERS LLC | 11,314,719 9.99% | 11,314,719 (New Position) | View |
2022-09-30 09:37 am Purchase | 13G | ALPINE IMMUNE SCIENCES INC. ALPN | GREAT POINT PARTNERS LLC | 3,448,521 7.85% | 3,448,521 (New Position) | View |
2022-07-08 5:13 pm Purchase | 13G | 89bio Inc. ETNB | GREAT POINT PARTNERS LLC | 2,100,000 5.29% | 2,100,000 (New Position) | View |
2022-07-01 2:35 pm Purchase | 13G | PRECISION BIOSCIENCES INC DTIL | GREAT POINT PARTNERS LLC | 5,755,396 5.89% | 5,755,396 (New Position) | View |
2022-05-18 4:03 pm Purchase | 13G | KalVista Pharmaceuticals Inc. KALV | GREAT POINT PARTNERS LLC | 1,280,000 5.22% | 1,280,000 (New Position) | View |
2022-02-14 11:23 am Sale | 13G | INFLARX N V COM IFRX | GREAT POINT PARTNERS LLC | 0 0% | -4,400,000 (Position Closed) | View |
2021-03-08 4:10 pm Purchase | 13G | INFLARX N V COM IFRX | GREAT POINT PARTNERS LLC | 4,400,000 9.69% | 4,400,000 (New Position) | View |
2021-02-16 4:13 pm Sale | 13G | ABEONA THERAPEUTICS INC. ABEO | GREAT POINT PARTNERS LLC | 0 0% | -8,488,882 (Position Closed) | View |
2021-02-16 4:13 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS INC CNST | GREAT POINT PARTNERS LLC | 1,024,800 2.15% | -1,276,657 (-55.47%) | View |
2021-02-16 4:13 pm Sale | 13G | GERON CORP GERN | GREAT POINT PARTNERS LLC | 12,754,228 4% | -10,342,889 (-44.78%) | View |
2021-02-16 4:13 pm Sale | 13G | TEMPEST THERAPEUTICS INC TPST | GREAT POINT PARTNERS LLC | 270,000 1.42% | -1,459,759 (-84.39%) | View |
2021-02-16 4:13 pm Sale | 13G | NEXTCURE INC NXTC | GREAT POINT PARTNERS LLC | 0 0% | -1,376,532 (Position Closed) | View |
2021-02-16 4:13 pm Sale | 13G | TG THERAPEUTICS, INC. TGTX | GREAT POINT PARTNERS LLC | 0 0% | -5,434,783 (Position Closed) | View |
2021-02-16 4:13 pm Sale | 13G | ZYMEWORKS INC ZYME | GREAT POINT PARTNERS LLC | 799,722 1.75% | -1,424,067 (-64.04%) | View |
2021-02-16 4:13 pm Sale | 13G | PROTHENA CORP PLC SHS PRTA | GREAT POINT PARTNERS LLC | 977,647 2.45% | -1,123,294 (-53.47%) | View |
2021-02-16 4:13 pm Unchanged | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | GREAT POINT PARTNERS LLC | 0 0% | 0 (Unchanged) | View |
2020-07-07 5:27 pm Purchase | 13G | ABEONA THERAPEUTICS INC. ABEO | GREAT POINT PARTNERS LLC | 8,488,882 9.99% | 8,412 (+0.10%) | View |
2020-06-05 5:00 pm Purchase | 13G | CONSTELLATION PHARMACEUTICALS INC CNST | GREAT POINT PARTNERS LLC | 2,301,457 5.5% | 2,301,457 (New Position) | View |